Comments on: Fangda Partners Assists Health Hope Pharma in Entering a Global Licensing Collaboration with Gilead for First-in-Class P-gp Inhibitor Encequidar

Comments on: Fangda Partners Assists Health Hope Pharma in Entering a Global Licensing Collaboration with Gilead for First-in-Class P-gp Inhibitor Encequidar /press-release/fangda-partners-health-hope-pharma-gilead-encequidar/ Thu, 23 Oct 2025 08:18:19 +0000 hourly 1